Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
As September concludes, the panorama of genitourinary (GU) oncology continues to evolve, with necessary developments in prostate, bladder, kidney and different GU...
A prognosis of kidney most cancers, also referred to as renal most cancers, requires robust partnership together with your oncologist. This overview...
